Ranked #804 of 8,699 institutional investors
Paradigm Biocapital Advisors LP
New York, NY
$5.07B
US stock portfolio at live prices · today −$52.3M (−1.02%)
Live prices, last trade 11:28 AM ET
- Value at quarter end (Q3 2026)
- $5.03B
- Change from Q2 2026
- −$311.6M (−5.83%)
- Positions
- 29 · 7 new, 4 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$3.8M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesRVMD 20.1%GMAB 14.2%EWTX 8.58%SYRE 8.38%INSM 7.74%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. | 6,219,323 | $1.02B | 20.1% | Reduced −2% |
| GMAB Genmab A/S | 14,136,472 | $721M | 14.2% | Added +8% |
| EWTX Edgewise Therapeutics, Inc. | 10,778,665 | $435M | 8.58% | Added +6% |
| SYRE Spyre Therapeutics, Inc. | 4,457,450 | $425M | 8.38% | Added +16% |
| INSM Insmed Incorporated | 2,695,977 | $393M | 7.74% | Added +103% |
| VRDN Viridian Therapeutics, Inc. | 8,257,672 | $254M | 5.01% | Added +23% |
| ORKA Oruka Therapeutics, Inc. | 2,493,507 | $234M | 4.60% | Added +16% |
| MBX MBX Biosciences, Inc. | 3,772,885 | $194M | 3.83% | Added +50% |
| BBIO BridgeBio Pharma, Inc. | 2,347,850 | $181M | 3.57% | New |
| TARS Tarsus Pharmaceuticals, Inc. | 2,301,375 | $172M | 3.40% | Reduced −17% |
| TNGX Tango Therapeutics, Inc. | 6,961,546 | $156M | 3.08% | Added +10% |
| BLTE Belite Bio, Inc | 1,142,123 | $149M | 2.94% | Reduced −7% |
| PCVX Vaxcyte, Inc. | 2,142,852 | $122M | 2.41% | Added +1% |
| ERAS Erasca, Inc. | 7,998,257 | $112M | 2.22% | Reduced −16% |
| JBIO Jade Biosciences, Inc. | 6,053,268 | $92.9M | 1.83% | Added +112% |
| TYRA Tyra Biosciences, Inc. | 3,510,360 | $70.5M | 1.39% | Added +92% |
| OLMA Olema Oncology, Inc. | 8,720,576 | $62.2M | 1.23% | Added +1% |
| OBX Obsidian Therapeutics, Inc. | 4,155,214 | $49.6M | 0.98% | New |
| MANE Veradermics Inc | 310,060 | $37.6M | 0.74% | New |
| ASMB Assembly Biosciences, Inc. | 1,553,748 | $34.5M | 0.68% | Unchanged |
| QUIT Achieve Life Sciences, Inc. | 4,951,856 | $28.3M | 0.56% | Unchanged |
| COAG Hemab Therapeutics Holdings, Inc. | 629,347 | $25.0M | 0.49% | New |
| KRSA Korsana Biosciences, Inc. | 613,914 | $22.9M | 0.45% | New |
| GPCR Structure Therapeutics Inc. | 1,299,199 | $21.5M | 0.42% | New |
| VOR Vor Biopharma Inc. | 889,575 | $17.6M | 0.35% | Reduced −49% |
| EDIT Editas Medicine, Inc. | 7,575,140 | $13.1M | 0.26% | Added +36% |
| ORIC ORIC Pharmaceuticals, Inc. | 1,505,769 | $11.4M | 0.23% | New |
| KARD Kardigan, Inc. | 900,000 | $11.0M | 0.22% | Unchanged |
| IVA Inventiva S.A. | 808,176 | $2.6M | <0.1% | Reduced −80% |